(Reuters) – The U.S. health regulator said on Thursday the current emergency use authorization (EUA) for Pfizer’s COVID-19 antiviral pill for high-risk adolescents will continue to remain in effect even if it receives full approval for use in some adults.
Latest posts by Crypto Editor (see all)
- Global Equity Indexes Show Interesting AB=CD Technical Confluence - March 29, 2023
- UAE appoints a vice president and a crown prince for Abu Dhabi - March 29, 2023
- Pope Francis has respiratory infection, needs hospital treatment - March 29, 2023
